Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Fust Matthew K disposed of 28,761 Crinetics Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Fust Matthew K (Director) disposed of 28,761 Crinetics Pharmaceuticals, Inc. shares at US$85.00 for US$2.44M, leaving 0 shares. Filed Sep 1, 2026 (Form 4).
- Disposed of
- 28,761 shares
- Price
- US$85.00
- Value
- US$2.44M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Disposition | 22,836 | US$85.00 | 5,925 | Direct |
| Sep 1, 2026 | Common Stock | Disposition | 5,925 | US$85.00 | 0 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Fust Matthew K
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Fust Matthew K · Jun 22, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Deardorf Caren · Sep 1, 2026